213 related articles for article (PubMed ID: 33972437)
1. A modular computational framework for medical digital twins.
Masison J; Beezley J; Mei Y; Ribeiro H; Knapp AC; Sordo Vieira L; Adhikari B; Scindia Y; Grauer M; Helba B; Schroeder W; Mehrad B; Laubenbacher R
Proc Natl Acad Sci U S A; 2021 May; 118(20):. PubMed ID: 33972437
[TBL] [Abstract][Full Text] [Related]
2. Fitness Studies of Azole-Resistant Strains of Aspergillus fumigatus.
Valsecchi I; Mellado E; Beau R; Raj S; Latgé JP
Antimicrob Agents Chemother; 2015 Dec; 59(12):7866-9. PubMed ID: 26416854
[TBL] [Abstract][Full Text] [Related]
3. Aspergillus fumigatus--what makes the species a ubiquitous human fungal pathogen?
Kwon-Chung KJ; Sugui JA
PLoS Pathog; 2013; 9(12):e1003743. PubMed ID: 24348239
[No Abstract] [Full Text] [Related]
4. The newly nonsporulated characterization of an Aspergillus fumigatus isolate from an immunocompetent patient and its clinic indication.
Zhang C; Kong Q; Cai Z; Liu F; Chen P; Song J; Lu L; Sang H
Fungal Genet Biol; 2015 Aug; 81():250-60. PubMed ID: 25776795
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous primary invasive cutaneous aspergillosis in two preterm twins: case report and review of the literature.
Gallais F; Denis J; Koobar O; Dillenseger L; Astruc D; Herbrecht R; Candolfi E; Letscher-Bru V; Sabou M
BMC Infect Dis; 2017 Aug; 17(1):535. PubMed ID: 28768499
[TBL] [Abstract][Full Text] [Related]
6. Pharmacodynamic effects of simulated standard doses of antifungal drugs against Aspergillus species in a new in vitro pharmacokinetic/pharmacodynamic model.
Meletiadis J; Al-Saigh R; Velegraki A; Walsh TJ; Roilides E; Zerva L
Antimicrob Agents Chemother; 2012 Jan; 56(1):403-10. PubMed ID: 22064546
[TBL] [Abstract][Full Text] [Related]
7. Implications of hypoxic microenvironments during invasive aspergillosis.
Wezensky SJ; Cramer RA
Med Mycol; 2011 Apr; 49 Suppl 1(Suppl 1):S120-4. PubMed ID: 20560863
[TBL] [Abstract][Full Text] [Related]
8. Identification and Characterization of a Novel Aspergillus fumigatus Rhomboid Family Putative Protease, RbdA, Involved in Hypoxia Sensing and Virulence.
Vaknin Y; Hillmann F; Iannitti R; Ben Baruch N; Sandovsky-Losica H; Shadkchan Y; Romani L; Brakhage A; Kniemeyer O; Osherov N
Infect Immun; 2016 Jun; 84(6):1866-1878. PubMed ID: 27068092
[TBL] [Abstract][Full Text] [Related]
9. Standardization of an experimental murine model of invasive pulmonary aspergillosis.
Sheppard DC; Graybill JR; Najvar LK; Chiang LY; Doedt T; Kirkpatrick WR; Bocanegra R; Vallor AC; Patterson TF; Filler SG
Antimicrob Agents Chemother; 2006 Oct; 50(10):3501-3. PubMed ID: 17005844
[TBL] [Abstract][Full Text] [Related]
10. Differences in pathogenicity and clinical syndromes due to Aspergillus fumigatus and Aspergillus flavus.
Pasqualotto AC
Med Mycol; 2009; 47 Suppl 1():S261-70. PubMed ID: 18654921
[TBL] [Abstract][Full Text] [Related]
11. Microbe Profile: Aspergillus fumigatus: a saprotrophic and opportunistic fungal pathogen.
Fang W; Latgé JP
Microbiology (Reading); 2018 Aug; 164(8):1009-1011. PubMed ID: 30066670
[TBL] [Abstract][Full Text] [Related]
12. Variation in vivo and isolation of aspergillus fumigatus from a case of human aspergillosis.
El-Ani AS
Mycologia; 1975; 67(6):1114-8. PubMed ID: 765815
[No Abstract] [Full Text] [Related]
13. Erg4A and Erg4B Are Required for Conidiation and Azole Resistance via Regulation of Ergosterol Biosynthesis in Aspergillus fumigatus.
Long N; Xu X; Zeng Q; Sang H; Lu L
Appl Environ Microbiol; 2017 Feb; 83(4):. PubMed ID: 27986720
[TBL] [Abstract][Full Text] [Related]
14. Assessment of carvacrol for control of avian aspergillosis in intratracheally challenged chickens in comparison to voriconazole with a reference on economic impact.
Tartor YH; Hassan FAM
J Appl Microbiol; 2017 Nov; 123(5):1088-1099. PubMed ID: 28795522
[TBL] [Abstract][Full Text] [Related]
15. Invasive aspergillosis involving multiple paranasal sinuses--a case report.
Agarwal S; Kanga A; Sharma V; Sharma DR; Sharma ML
Indian J Med Microbiol; 2005 Jul; 23(3):195-7. PubMed ID: 16100430
[TBL] [Abstract][Full Text] [Related]
16. New advances in invasive aspergillosis immunobiology leading the way towards personalized therapeutic approaches.
Obar JJ; Hohl TM; Cramer RA
Cytokine; 2016 Aug; 84():63-73. PubMed ID: 27253487
[TBL] [Abstract][Full Text] [Related]
17. SCH56592 treatment of murine invasive aspergillosis.
Graybill JR; Bocanegra R; Najvar LK; Luther MF; Loebenberg D
J Antimicrob Chemother; 1998 Oct; 42(4):539-42. PubMed ID: 9818757
[TBL] [Abstract][Full Text] [Related]
18. In Vivo Synergy of Amphotericin B plus Posaconazole in Murine Aspergillosis.
Martin-Vicente A; Capilla J; Guarro J
Antimicrob Agents Chemother; 2016 Jan; 60(1):296-300. PubMed ID: 26503653
[TBL] [Abstract][Full Text] [Related]
19. cipC is important for Aspergillus fumigatus virulence.
Canela HM; Takami LA; da Silva Ferreira ME
APMIS; 2017 Feb; 125(2):141-147. PubMed ID: 28120495
[TBL] [Abstract][Full Text] [Related]
20. Activation of platelets by Aspergillus fumigatus and potential role of platelets in the immunopathogenesis of Aspergillosis.
Rødland EK; Ueland T; Pedersen TM; Halvorsen B; Muller F; Aukrust P; Frøland SS
Infect Immun; 2010 Mar; 78(3):1269-75. PubMed ID: 20008537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
